A functional assessment tool to distinguish controls from Alzheimer’s disease in Lima, Peru

dc.date.accessioned2023-04-05T12:48:05Z
dc.date.available2023-04-05T12:48:05Z
dc.date.issued2022
dc.description.abstractBackground: The Alzheimer’s Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) scale is a versatile functional assessment tool for patients with Alzheimer’s disease (ad). We evaluated its performance in controls, Peruvians with MCI or AD. Methods: A cross-sectional study of older adults attending a neurology institute in Lima (Peru) with mild cognitive impairment (MCI), ad or cognitively healthy. Test-retest reliability (intraclass correlation coefficient, ICC; internal consistency, Cronbach’s alpha) and validity were assessed. Results: We enrolled 276 individuals (ad: 113, MCI: 68, controls: 95) with no age, sex, educational level, and depressive symptom differences. Reliability was ideal (ICC:.996), and Cronbach’s alpha was adequate (.937). The ADCS-ADL could not differentiate MCI from controls but did differentiate ad severity. The ADCS-ADL correlated highly with nearly all tools. Conclusions: The ADCS-ADL scale is reliable in a population with ad in Lima, Peru. Future work may validate a tool for Peruvians with lower educational levels. © The Author(s) 2022.
dc.identifier.issn15333175
dc.identifier.urihttps://doi.org/10.1177/15333175221104354
dc.identifier.urihttp://146.190.124.33/handle/123456789/6190
dc.language.isoenges_ES
dc.publisherSAGE Publications Inc.es_ES
dc.sourceRevista Cubana de Medicina General Integral; Vol. 37 Núm. Special Issue
dc.titleA functional assessment tool to distinguish controls from Alzheimer’s disease in Lima, Perues_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.type.versioninfo:eu-repo/semantics/publishedVersion
Archivos
Colecciones